IMS Stock Overview
Invent Medic Sweden AB (publ), a femtech company, engages in the development of non-invasive aid for women’s health in Sweden and internationally. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Invent Medic Sweden AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.82 |
52 Week High | SEK 1.20 |
52 Week Low | SEK 0.49 |
Beta | 1.05 |
1 Month Change | 0% |
3 Month Change | 0.74% |
1 Year Change | -21.53% |
3 Year Change | -87.19% |
5 Year Change | -92.44% |
Change since IPO | -77.16% |
Recent News & Updates
Recent updates
Shareholder Returns
IMS | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 0% | -0.1% | 0.3% |
1Y | -21.5% | -0.04% | 13.5% |
Return vs Industry: IMS underperformed the Swedish Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: IMS underperformed the Swedish Market which returned 8.6% over the past year.
Price Volatility
IMS volatility | |
---|---|
IMS Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.9% |
Market Average Movement | 5.6% |
10% most volatile stocks in SE Market | 12.2% |
10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: IMS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IMS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 8 | Anna Lindstrom | www.inventmedic.se |
Invent Medic Sweden AB (publ), a femtech company, engages in the development of non-invasive aid for women’s health in Sweden and internationally. It offers bladder support, a CE-marked and patented medical device against stress incontinence; and menstrual cups and accessories. The company offers its products under Efemia and FlowCup brands.
Invent Medic Sweden AB (publ) Fundamentals Summary
IMS fundamental statistics | |
---|---|
Market cap | SEK 32.94m |
Earnings (TTM) | -SEK 8.53m |
Revenue (TTM) | SEK 6.71m |
4.9x
P/S Ratio-3.9x
P/E RatioIs IMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IMS income statement (TTM) | |
---|---|
Revenue | SEK 6.71m |
Cost of Revenue | SEK 1.49m |
Gross Profit | SEK 5.22m |
Other Expenses | SEK 13.75m |
Earnings | -SEK 8.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
Earnings per share (EPS) | -0.21 |
Gross Margin | 77.77% |
Net Profit Margin | -127.21% |
Debt/Equity Ratio | 50.5% |
How did IMS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/04/29 18:29 |
End of Day Share Price | 2024/01/31 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Invent Medic Sweden AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.